Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Other Non-Current Assets (2022 - 2026)

Oculis Holding AG (OCS) posted quarterly Other Non-Current Assets of $1.0 million for Q1 2026, up 79.9% year-over-year from $565023.3 in Q1 2025, and up 3.5% quarter-over-quarter from $982168.3 in Q4 2025.

Analysis

Oculis Holding AG (OCS) Other Non-Current Assets (2022 - 2026) Analysis & Trends

Oculis Holding AG's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 79.9% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 79.9% YoY), while the FY2025 annual figure was $946810.9, up 74.99% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $1.0 million, up from $982168.3 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $1.0 million in Q1 2026, with the low at $76813.6 in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $196831.2 (2024), against an average of $411139.4.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets advanced 25.66% in 2024, then surged 466.87% in 2025.
  • Oculis Holding AG's Other Non-Current Assets stood at $76813.6 in 2022, then soared by 30.62% to $100334.5 in 2023, then jumped by 441.55% to $543364.4 in 2024, then surged by 80.76% to $982168.3 in 2025, then grew by 3.5% to $1.0 million in 2026.
  • Business Quant data shows OCS's Other Non-Current Assets at $1.0 million in Q1 2026, $982168.3 in Q4 2025, and $665058.3 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn - 1.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.07 Mn
Mar 31, 2026 1.02 Mn
Dec 31, 2025 982,168.29
Sep 30, 2025 665,058.26
Jun 30, 2025 643,805.49
Mar 31, 2025 565,023.27
Dec 31, 2024 543,364.40
Sep 30, 2024 183,518.95
Jun 30, 2024 196,831.24
Mar 31, 2024 99,674.36
Dec 31, 2023 9.57 Mn
Sep 30, 2023 146,047.68
Jun 30, 2023 125,675.84
Dec 31, 2022 76,813.62